Microline Surgical

Executive Summary

Microline Surgical, a wholly owned subsidiary of HOYA Corporation, is a US-based medical device company specializing in minimally invasive surgical instruments. The company's core innovation lies in its 'reposable' instrument platform, which combines reusable handpieces with disposable sterile tips, offering a cost-effective and environmentally sustainable alternative to fully disposable devices. This hybrid approach reduces waste and lowers per-procedure costs for healthcare facilities, addressing key pain points in surgical supply management. Founded in 1988 and headquartered in Beverly, Massachusetts, Microline has a long history of developing precision instruments for laparoscopic, thoracic, and other minimally invasive procedures. With HOYA's global resources and distribution network, Microline is well-positioned to expand its market share in the competitive surgical device landscape. The company's products are designed to enhance surgical outcomes while reducing the financial and environmental burden on hospitals. As healthcare systems increasingly prioritize sustainability and cost efficiency, Microline's reposable platform offers a compelling value proposition. The company is poised for growth through product line extensions, geographic expansion, and potential new regulatory clearances, supported by HOYA's strategic investment in medical technology.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation reposable surgical instruments70% success
• Q2 2026FDA clearance for expanded device indication in laparoscopic surgery60% success
• Q1 2027Strategic partnership or distribution agreement for European market entry50% success